{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:10:06Z","timestamp":1790187006112,"version":"4.1.0"},"reference-count":28,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background\/Purpose<\/jats:title>\n                    <jats:p>APS ACTION Registry was created to study the natural course of antiphospholipid syndrome (APS) over 10 years in persistently antiphospholipid antibody (aPL) positive patients with or without systemic autoimmune rheumatic diseases (SARDs). Our primary objective was to compare the characteristics of aPL-positive patients with or without thrombocytopenia (TP) and\/or autoimmune hemolytic anemia (AIHA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The registry inclusion criteria are positive aPL based on the Revised Sapporo APS Classification Criteria, tested at least twice within 1\u00a0year prior to enrollment. For the primary comparison of demographic, clinical, and serologic characteristics in this retrospective study, we divided patients into two groups: TP\/AIHA ever and never. Thrombocytopenia was defined as a platelet count of &lt;100,000 x 10\n                      <jats:sup>9<\/jats:sup>\n                      \/L tested twice at least 12\u2009weeks apart, and AIHA was defined as anemia with hemolysis and a positive direct antiglobulin test (DAT). For the secondary analysis, we compared patients with TP versus AIHA, and the immunosuppressive use stratified by systemic lupus erythematosus (SLE) classification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      As of April 2022, of 1,039 patients (primary aPL\/APS: 618 [59%]; SLE classification: 334 [31%]) included in the registry, 228 (22%) had baseline (historical or current) TP and\/or AIHA (TP only: 176 [17%]; AIHA only: 35 [3%], and both: 17 [2%]). Thrombocytopenia and\/or AIHA was significantly associated with Asian race, SLE classification, cardiac valve disease, catastrophic\/microvascular APS, triple aPL (lupus anticoagulant, anticardiolipin antibody, and anti-\u03b2\n                      <jats:sub>2<\/jats:sub>\n                      -glycoprotein-I antibody) positivity, and SLE-related serologic and inflammatory markers. When 101\/618 (16%) primary aPL\/APS patients and 101\/334 (34%) SLE patients with TP and\/or AIHA were compared, azathioprine and mycophenolate mofetil were more commonly reported in lupus patients, however corticosteroid, intravenous immunoglobulin, and rituximab use were similar between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In our large multi-center international cohort of persistently aPL-positive patients, approximately one-fifth had active or historical TP and\/or AIHA at registry entry; half of these patients had additional SLE. Cardiac valve disease, catastrophic\/microvascular APS, and triple aPL-positivity were aPL-related clinical and laboratory manifestations associated with TP and\/or AIHA, suggesting a more severe APS clinical phenotype in aPL-patients with TP and\/or AIHA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09612033251332258","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T04:25:16Z","timestamp":1743740716000},"page":"617-625","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (\u201cRegistry\u201d)"],"prefix":"10.1177","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9099-8649","authenticated-orcid":false,"given":"Zeynep Belce","family":"Erton","sequence":"first","affiliation":[{"name":"SUNY Downstate Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Leaf","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0381-1808","authenticated-orcid":false,"given":"Danieli","family":"de Andrade","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Clarke","sequence":"additional","affiliation":[{"name":"University of Calgary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-0975","authenticated-orcid":false,"given":"Maria G.","family":"Tektonidou","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-6071","authenticated-orcid":false,"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[{"name":"Padova University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1266-9441","authenticated-orcid":false,"given":"Savino","family":"Sciascia","sequence":"additional","affiliation":[{"name":"ASL Citt\u00e0 Di Torino and University of Turin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Pardos-Gea","sequence":"additional","affiliation":[{"name":"BioCruces Bizkaia Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kello","sequence":"additional","affiliation":[{"name":"Northwell Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Paredes-Ruiz","sequence":"additional","affiliation":[{"name":"Biobizkaia Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chary","family":"Lopez-Pedrera","sequence":"additional","affiliation":[{"name":"University of Cordoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Michael","family":"Belmont","sequence":"additional","affiliation":[{"name":"New York University Langone Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Fortin","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Laval"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6715-0180","authenticated-orcid":false,"given":"Guilherme","family":"Ramires de Jes\u00fas","sequence":"additional","affiliation":[{"name":"Universidade Do Estado Do Rio de Janeiro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[{"name":"Hokkaido University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Peking University First Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Efthymiou","sequence":"additional","affiliation":[{"name":"University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1718-5094","authenticated-orcid":false,"given":"D. Ware","family":"Branch","sequence":"additional","affiliation":[{"name":"University of Utah and Intermountain Healthcare"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pazzola","sequence":"additional","affiliation":[{"name":"Azienda USL IRCCS di Reggio Emilia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[{"name":"University of Brescia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-5719","authenticated-orcid":false,"given":"Al\u00ed","family":"Duarte-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Mayo Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-5644","authenticated-orcid":false,"given":"Esther","family":"Rodriguez-Almaraz","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1441-5373","authenticated-orcid":false,"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[{"name":"Johns Hopkins University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6085-492X","authenticated-orcid":false,"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[{"name":"Hospital Clinic Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5659-3955","authenticated-orcid":false,"given":"Bahar","family":"Artim-Esen","sequence":"additional","affiliation":[{"name":"Istanbul University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0643-2755","authenticated-orcid":false,"given":"Rosana","family":"Quintana","sequence":"additional","affiliation":[{"name":"Centro Regional de Enfermedades Autoinmunes y Reum\u00b4aticas Del Grupo Orono (GO-CREAR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[{"name":"Ruijin Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6721-7755","authenticated-orcid":false,"given":"Yu","family":"Zuo","sequence":"additional","affiliation":[{"name":"University of Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1374-7678","authenticated-orcid":false,"given":"Rohan","family":"Willis","sequence":"additional","affiliation":[{"name":"University of Texas Medical Branch"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan R W","family":"Barber","sequence":"additional","affiliation":[{"name":"University of Calgary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Skeith","sequence":"additional","affiliation":[{"name":"University of Calgary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-2606","authenticated-orcid":false,"given":"Massimo","family":"Radin","sequence":"additional","affiliation":[{"name":"ASL Citt\u00e0 Di Torino and University of Turin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3394-1451","authenticated-orcid":false,"given":"PierLuigi","family":"Meroni","sequence":"additional","affiliation":[{"name":"Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Auxologico Italiano"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-139X","authenticated-orcid":false,"given":"Maria Laura","family":"Bertolaccini","sequence":"additional","affiliation":[{"name":"King\u2019s College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-390X","authenticated-orcid":false,"given":"Hannah","family":"Cohen","sequence":"additional","affiliation":[{"name":"University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Roubey","sequence":"additional","affiliation":[{"name":"University of North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[{"name":"Hospital for Special Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203312437810"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24468"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2008.03.005"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23584"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac264"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13947"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.46497\/ArchRheumatol.2022.9088"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.3.194"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.42624"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab475"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198911000-00003"},{"key":"e_1_3_5_16_2","first-page":"230","volume-title":"Current Diagnosis & Treatment: Rheumatology","author":"Gkrouzman E","year":"2021","unstructured":"Gkrouzman E, Erkan D. Antiphospholipid syndrome. In: Stone JH (ed). Current Diagnosis & Treatment: Rheumatology. 4th ed. New York: McGraw Hill, 2021, pp. 230\u2013235.","edition":"4"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(17)30066-X"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310395803"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705454"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211060581"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032949"},{"key":"e_1_3_5_23_2","first-page":"34","article-title":"Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome","volume":"89","author":"Erdozain JG","year":"2004","unstructured":"Erdozain JG, Ruiz-Irastorza G, Egurbide MV, et al. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome. Haematologica 2004; 89: 34.","journal-title":"Haematologica"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2019.100648"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003808"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00144-3"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-55442-6_8"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224952"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24508"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033251332258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033251332258","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033251332258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:28:52Z","timestamp":1777678132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033251332258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/09612033251332258"],"URL":"https:\/\/doi.org\/10.1177\/09612033251332258","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}